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B r i e f c o m m u n i c at i o n s
In the peripheral nervous system, the 'trigger' of myelination is axon size (> 1 µm), a threshold mediated by Nrg1 type III on the axon surface 1 . Since Nrg1 is not required for CNS myelination 2 , we asked whether axon size can be experimentally increased here by the absence of PTEN (ref. 3) , i.e., with phosphatidylinositol-3,4,5-trisphosphate (PI(3,4,5)P 3 ) stimulating the AKT1-mTOR pathway (Fig. 1a) . To specifically enlarge cerebellar granule cells (GC) and their naturally unmyelinated parallel fiber (Pf) axons, we generated Tg(mα6)-Cre;Pten loxP/loxP mice 4, 5 . Reporter gene expression shows that recombination begins at postnatal day (P) 9 in predominantly postmitotic GC 4 . The cerebellum of Tg(mα6)-Cre;Pten loxP/loxP mice (hereafter termed Pten cKO or 'mutants') revealed a loss of Pten mRNA (−63%; Fig. 1b ) and protein (−80%; n = 3 each genotype; P = 0.0025, t = 6.788, d.f. = 4, two-tailed unpaired Student's t-test; Fig. 1c ) compared to Pten loxP/loxP mice (hereafter termed 'controls') at age 3.5 months. Loss of PTEN resulted in enhanced phosphorylation of well-known downstream targets of the PI3K pathway (Fig. 1d) .
Mutant mice appeared healthy (Supplementary Video 1), but cerebellar GC layer (GL) and molecular layer (ML) progressively enlarged ( Fig. 1e and Supplementary Fig. 1a) . Immunostaining of GABA A receptor α6 revealed a gradual size increase of GC somata (Supplementary Fig. 1b) . Older mice developed ataxia and tremor (Supplementary Video 2), possibly due to hamartomas at advanced age ( Supplementary Fig. 2 and Supplementary Note).
The diameters of Pf axons also increased over time, as quantified by electron microscopy (EM), reaching 0.61 ± 0.009 µm (mean ± s.e.m.) in mutants in comparison to 0.16 ± 0.002 µm in controls at 1 year of age (Fig. 1f,g and Supplementary Fig. 1c) . Importantly, radial Pf growth in mutant brains was associated with substantial myelination beginning at age P40 (2.3 ± 0.6% myelinated Pf axons) and progressing over time (3 months: 9.5 ± 1% myelinated Pf axons). At 1 year of age, up to 40 ± 3% of Pf axons were myelinated with an average g-ratio (the ratio between the diameter of the axon itself and the outer diameter of the myelinated fiber) of 0.84. Myelination was visualized by Gallyas silver impregnation ( Supplementary Fig. 3a ) and anti-CNP immunohistochemistry ( Fig. 1h and Supplementary Fig. 3b ), including whole-mount immunolabeling combined with light sheet and two-photon microscopy (Supplementary Video 3), as well as EM ( Fig. 1i-k) . We determined a 'size threshold' of approximately 0.25 µm for myelination at all ages tested (Fig. 1k,l) . Myelinated Pf axon segments were very rarely seen in controls.
De novo myelination included the formation of nodes and paranodes with septate-like junctions (Fig. 1j ) and the clustering of Caspr and Na V 1.6 on axons (Fig. 1m,n) . GC synaptic contacts to Purkinje cell dendrites were restricted to Pf 'nodal' regions ( Fig. 1o and Supplementary Fig. 4 ).
The ML normally harbors very few oligodendrocytes and only scattered oligodendrocyte progenitor cells (OPCs), as demonstrated in Plp1-DsRed;Ng2-EYFP double-transgenic mice (Fig. 2a) . In Pten mutants at P45, mature oligodendrocytes were increased in the GL (+33%) and more prominent in the ML (+750%) but unaltered in cerebellar white matter (Fig. 2b) . To determine whether OPCs proliferate in the ML or are recruited from the GL, we combined immunostaining with BrdU labeling (Fig. 2c) . After 20 d of daily BrdU injections (P25-P45), OPC proliferation (BrdU + Olig2 + ) was the same in GL or white matter of mutants and controls (Fig. 2d) . However, OPC proliferation in the mutant ML increased 4.4-fold. Even at age 6-7 months, we found a 4.7-fold increase of BrdU + Olig2 + cells. This suggests that local proliferation was stimulated (directly or indirectly) by GC axonderived signals, which must still have been present at older ages. At that time, oligodendrocyte lineage cells in mutants were increased tenfold over the numbers present in controls (Fig. 2d) . By following different BrdU protocols, we identified a time window (P20-P30) in which proliferation of OPCs was already increased but the number of CNP + oligodendrocytes was not yet altered (Fig. 2e,f) . This strongly suggests that OPC proliferation was not merely a homeostatic mechanism B r i e f c o m m u n i c at i o n s to replace differentiated OPCs but was an early response to the neuronal trigger. Accordingly, BrdU + Olig2 + OPCs were uniformly distributed in the ML and not preferentially detected in proximity to newly generated MBP + oligodendrocytes (Fig. 2g) . Double-labeling for BrdU and carbonic anhydrase II (CAII), a marker of mature oligodendrocytes, confirmed that newly generated OPCs had responded to elevated differentiation signals (Fig. 2h) . At 7 months, the ML in Pten-mutant brains still contained 'maturating' Fig. 2i) , an early marker almost undetectable in fully mature cells (B. Emery, personal communication). Taken together, our data suggest that Pten-mutant GC and thus a PI(3,4,5)P 3 -dependent neuronal program is sufficient to drive oligodendrocyte lineage cells through all developmental stages. However, we cannot formally exclude the theoretical possibility that normally myelinated axons recruit OPCs and induce myelination by completely different mechanisms. Formally, activation of neuronal AKT1-mTOR would not be the 'initiating' event itself, if other more rate-limiting steps are regulated upstream.
OPCs receive synaptic input that could modulate proliferation and myelination 6 . Using acute slices from mutant and control mice (both additionally expressing an Ng2-EYFP transgene 7 ), we whole-cell patch-clamped both Purkinje cells, which get input predominantly from Pf axons, and fluorescent OPCs in the ML. This allowed us to determine GC spiking activity as well as the synaptic inputs from Pf axons to OPCs. We found no difference between mutant and control OPCs for the frequency of spontaneous synaptic Pf inputs or for the Pf inputs to Purkinje cells (Fig. 2j-m) . Also, the fraction of OPCs that received detectable input was not different (controls: 39%; mutants: 47%; χ 2 = 0.87, P = 0.4, chi-squared test). Thus, de novo myelination is unlikely to be the result of an underlying alteration of Pf spiking activity or of changes in synaptic input to OPCs ( Supplementary  Fig. 5 and Supplementary Note).
Theoretically, Pf myelination could be caused by downregulating inhibitory neuronal signals. We addressed this by targeting only a small fraction of sparsely distributed GC, using Nex-CreERT2 mice 8 . After 5 d of tamoxifen (P10-P15), reporter gene expression marked < 4% of all GC (Supplementary Fig. 6a ). However, when analyzed 28 weeks later (Supplementary Fig. 6b ), we still found a significant increase of mature oligodendrocytes (P < 0.0001, t = 19, d.f. = 4) and myelinated areas (P = 0.009, t = 4.730, d.f. = 4) in the ML of Nex-CreERT2;Pten loxP/loxP mice ( Supplementary Fig. 6c-f ) making it highly unlikely that soluble inhibitors, still expressed by 96% of nonrecombined GC, must be downregulated to initiate myelination. In these mice, de novo myelination was also observed when tamoxifen was given at age 7 months (data not shown), arguing strongly against Pten cKO, P < 0.0001, t = 16.53; Pten cKO vs. Pten cKO;Bdnf cKO, P = 0.0426, t = 2.565, F = 56.01, d.f. = 13; quantified in the ML of parasagittal sections of the cerebellar vermis; n = 3-4 mice per genotype). Data are mean ± s.e.m.; n.s., not significant; *P < 0.05, **P < 0.01, ***P < 0.001; two-tailed unpaired Student's t-test in f and h or one-way ANOVA followed by Bonferroni test in c, e and i. Images in a, b and d are representative of ≥ 3 similar experiments.
B r i e f c o m m u n i c at i o n s a critical period in development at which the identified PI(3,4,5)P 3 -dependent neuronal program can trigger myelination.
Searching for promyelinating factors, we laser-captured stripes of GL from cryosections of 3-month-old mutants and controls for transcriptome analyses (Fig. 3a) . A resulting list of candidate genes upregulated in Pten cKO was further selected by annotation (Supplementary Table 1 ) and validated with reverse transcription quantitative real-time PCR (qPCR; data not shown).
To confirm the significance of these findings in vivo, we tested Bdnf (ref. 9) , reasoning that its inactivation might affect de novo myelination. Unexpectedly, Tg(mα6)-Cre;Pten loxP/loxP ;Bdnf loxP/loxP mice (hereafter termed Pten;Bdnf double mutants) exhibited a higher (not lower) number of oligodendrocytes in the ML compared to Pten single mutants (Fig. 3b,c) . Immunostaining also showed that the myelinated area of the ML was not smaller but larger (Fig. 3d,e) . By EM, we confirmed that Pf axon calibers were as enlarged in Pten;Bdnf double mutants as in Pten single mutants (Fig. 3f) . However, g-ratio analysis showed that myelin was thinner in Pten;Bdnf double mutants than in Pten single mutants (Fig. 3g,h) . Thus, in the absence of Bdnf, mutant oligodendrocytes are more numerous in the ML, but each fiber is only thinly ensheathed. Most likely, OPCs respond to either proliferation or differentiation signals but not to both. In the absence of Bdnf (a differentiation signal), the weight of proliferation signals might increase, driving the number of OPCs up. However, differentiation signals may compensate later and turn all OPCs into oligodendrocytes, explaining a seemingly paradoxical result.
To test this hypothesis directly, we compared OPC proliferation in Pten;Bdnf double mutants and single mutants at 7 weeks of age, following BrdU labeling (P25-P45). Indeed, double mutants showed 34% more BrdU-labeled (Olig2 + ) OPCs in the ML than Pten single mutants (Fig. 3i) . Unexpectedly, the lack of Bdnf even promoted proliferation of OPCs in heterozygous Pten mutants compared to controls (Fig. 3i) . This suggests that Bdnf helps control the number of OPCs, which are likely to turn over in the absence of other myelination-promoting factors. For comparison, Nrg1 (essential for myelination by Schwann cells 1 ) revealed no such effects on de novo myelination in Tg(mα6)-Cre;Pten loxP/loxP ;Nrg1 loxP/loxP mice (Supplementary Fig. 7) .
Because of the complexity of Bdnf effects in vivo, we studied other candidate factors (emerging from our screen) in primary oligodendrocyte cultures and in myelinating neuron-oligodendrocyte cocultures, using recombinant proteins to test their role in OPC proliferation, differentiation and/or myelination. Indeed, Fgf1 stimulated proliferation of OPCs (Supplementary Figs. 8a-d and 9 , and Supplementary Note). Activin-A, the biologically active dimer of two inhibin beta A (Inhba) subunits, emerged as a differentiation factor 10 that required MAPK (ERK1 and ERK2) but not PI3K or SMAD3 (Supplementary Fig. 8e-i and Supplementary Note) to be effective. Pleiotrophin, Tmsb4x and Timp3 also stimulated in vitro myelination (Supplementary Fig. 8g,h and Supplementary Note).
Increased axon size was further associated with upregulated expression of several other genes. Some mRNAs encoded secreted proteins already associated with oligodendrocyte development such as Bdnf, Vegfc and Tmsb4x (refs. 9,11,12) . Other factors, including Fstl1, Igfbp-4, Dkk-3, Apcdd1 and Sfrp4, are known antagonists of Wnt and Bmp signaling 13, 14 , inhibit oligodendrocyte differentiation 15 . Modulators of IGF signaling and metallopeptidases (MMP17, Adamts1) were also upregulated, the latter degrading inhibitors of remyelination. We note that membrane proteins not transcriptionally upregulated may also increase in abundance when axons grow radially.
Taken together, we have identified an upstream neuronal 'switch' , the PI3K-AKT1-mTOR pathway, which was sufficient to trigger the entire program of radial axonal growth 16 , recruitment of OPCs and progressive myelination in the CNS. Axonal specializations, such as the clustering of Caspr at paranodal junctions, were part of this neuronal myelination program. Myelination was triggered by a combination of both the increase of axon caliber (> 0.25 µm) and the induced expression of numerous promyelinating factors. Axon caliber poses a critical threshold for myelination in the peripheral and central nervous system, as recently shown for cultured oligodendrocytes myelinating carbon nanofibers 17 . However, CNS myelination begins with OPC recruitment and expansion, followed by oligodendrocyte differentiation, all without axonal contact. Only once differentiated oligodendrocytes physically engulf axons is the minimum caliber required to allow membrane wrapping. Schwann cells, in contrast, are always physically associated with axons and stimulated by a key membrane-bound growth factor, Nrg1 type III (ref. 1).
Downstream of the neuronal myelination switch, not all promyelinating factors are of neuronal origin, in line with previous findings 10 . We also identified immune modulatory factors that were upregulated, such as Nts (neurotensin) and Ninj1 (ninjurin 1), previously implicated in immune cell migration 18, 19 . Since moderate changes in Iba1, Mac-3 and GFAP expression were detected in the mutant ML ( Supplementary Fig. 10a-c) , we asked whether non-neuronal cells responded to Pten deletion in Nex-CreERT2;Pten loxP/loxP mutants (which showed only 4% GC recombination but significant myelination). Here, no 'gliosis' markers were detected in ML and GL, even 28 weeks after recombination (Supplementary Fig. 11 ). Thus, de novo myelination was not dependent on any form of gliosis.
Moreover, several factors were expressed in endothelial cells (Supplementary Table 1 ) and CD31 immunostaining showed increased angiogenesis in the mutant GL (Supplementary Fig. 10d ). This is in line with the recently identified coupling of myelination to angiogenesis 20 .
Notably, not all Pten mutant neurons were myelinated, as evidenced by hippocampal neurons in Nex-CreERT2;Pten loxP/loxP mutants. Despite efficient recombination of hippocampal CA3 neurons 8 and significant increase in the size of neuronal somata (P = 0.0005, t = 10.18, d.f. = 4), Schaffer collateral axons remained unmyelinated (Supplementary Fig. 12 ). This suggests a role of inhibitory signals that may 'protect' axons from myelination, which would interfere with sprouting and neuronal plasticity in the adult. However, we have no formal proof that all axons were sufficiently enlarged, as EM sections did not allow us to positively identify the Schaffer collaterals.
In multiple sclerosis, lesioned areas fail to repair, presumably because of a poor balance of myelination promoting and inhibiting cues. Significant progress has been made in identifying small molecules targeting OPCs and oligodendrocytes in remyelination. Our data suggest that neurons should also be considered as therapeutic targets when searching for myelin repair strategies.
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ONLINe MeThOdS mouse mutants. All experiments were conducted according to the Lower Saxony State regulations for the use of experimental animals in Germany as approved by the Niedersächsische Landesamt für Verbraucherschutz und Lebensmittelsicherheit (LAVES) and according to UK government animal use regulations. Mice were housed in groups in individually ventilated cages under a 12:12 h light/dark cycle with access to food and water ad libitum. If not stated otherwise, for molecular, histological, electrophysiological, electron microscopic and biochemical experiments, female and male mice were included in the experiments and were randomly allocated to experimental groups according to age and genotype. All animal experiments were conducted in a single-blinded fashion toward the investigator. Inclusion/exclusion criteria were pre-established. Animals were excluded from the experiment when showing impaired health conditions not attributable to genotype or experiment or when the weight difference between the individual animal and the average group weight was larger than 10%. With respect to the outcome assessment, exclusion criteria were determined with Grubbs' test (ESD method), using the statistical software GraphPad (Prism). No animals or samples had to be excluded with these criteria in any of the experiments.
Mice mutant for Pten loxP/loxP , Tg(mα6-Cre)B1LFR, Nex-CreERT2, Nrg1 loxP/loxP , Bdnf loxP/loxP , Plp1-DsRed, Rosa26-lacZ and Ng2-EYFP were genotyped as described 4, 5, 7, 8, [21] [22] [23] [24] . Tg(mα6-Cre)B1LFR, Nex-CreERT2, Nrg1 loxP/loxP , Bdnf loxP/loxP , Plp1-DsRed, Rosa26-lacZ and Ng2-EYFP mutants were on a C57BL/6N background, whereas Pten loxP/loxP mutants and thus all compound mutants harboring Pten loxP alleles were on a mixed C57BL/6N-SV129 background. For genotyping, genomic DNA was isolated from tail biopsies (InvisorbSpin Tissue Mini kit, Invitek) according to the manufacturer's directions and subjected to routine PCR methods using the following primers:
Pten sense: 5′-ACTCAAGGCAGGGATGAGC-3′ and antisense: 5′-CAGAG TTAAGTTTTTGAAGGCAAG-3′;
Tg(mα6-Cre)B1LFR sense: 5′-TAGAGCATTAGGGTGGGAG-3′ and antisense: 5′-TGCCGCCTTTGCAGGTGTGTCTTAC-3′;
Nrg1 sense: 5′-GCACCAAGTGGTTGCGATTGTTGCT-3′ and antisense: 5′-TCCTTTTGTGTGTGTTCAGCACCGG-3′;
Bdnf sense: 5′-GTTGCGTAAGCTGTCTGTGCACTGTGC-3′ and antisense: 5′-CAGACTCAGAGGGCACTTTGATGGCTTG-3′
Plp1-DsRed sense: 5′-CGCCGACATCCCCGACTACAA-3′ and antisense: 5′-GCGGCCGCTACAGGAACAGGT-3′;
Rosa26-lacZ sense: 5′-AAAGTCGCTCTGAGTTGTTAT-3′ and antisense: 5′-GCGAAGAGTTTGTCCTCAACC-3′; and Ng2-EYFP sense: 5′-TGACCTTGGATTCTGAGC-3′ and antisense: 5′-CGCTGAACTTGTGGCCGTTTA-3′.
BrdU labeling. Mice received 5′-bromodeoxyuridine (BrdU, Sigma Aldrich) by daily intraperitoneal injections (50 µg/g of body weight) for 5, 10 or 20 consecutive days. Mice were killed for analysis 4 h or 4 d after the final injection.
Histology and immunohistochemistry.
Mice were anaesthetized with Avertin (Sigma-Aldrich) and perfused with 15 ml of Hank's balanced salt solution (HBSS, PAA Laboratories, Pasching, Austria) followed by fixative (4% PFA, 0.1M Phosphate buffer, 0.5% NaCl). Paraffin sections of the brain (5 µm) were deparaffinized using xylene and isopropanol and rehydrated in a descending ethanol series. Antigen unmasking was performed by boiling for 10-40 min in citric buffer, pH 6, or Tris EDTA, pH 9. Sections were blocked in 20% goat serum in PBS/BSA for 1 h and incubated with primary antibodies in 5% goat serum in PBS/BSA for 2 h at 37 °C or overnight at 4 °C. Detection was performed using Alexa Fluor 488-, 555-and 633-conjugated secondary antibodies (1:1,000, Thermo Fisher Scientific, #A-28175, #A-11034, #A-21212, #A-21422, #A-27039 and #A-21094) and biotinylated secondary antibodies, followed by diaminobenzidine (DAB; LSAB2 Kit, Dako, #K0675; Vectastain Kit, Vector Laboratories, #BA-9400 and #PK-6100). Primary antibodies were directed against BrdU . We also stained 5 µm microtome sections (Microm HM400) with hematoxylin-eosin (HE) to study cytoarchitecture. Myelinated fibers were visualized by Gallyas silver impregnation as described 25 . All images showing immunohistochemical analyses and stainings were successfully repeated at least three times. iDISCO whole-mount anti-CNP immunohistochemistry was performed according to the published protocol 26 on dissected cerebella from control and mutant animals. Monoclonal anti-CNP primary antibody (1:200, Sigma, #C5922) was used with 4 d incubation at 37 °C. Donkey anti-mouse Alexa Fluor 647-conjugated secondary antibody (1:1,000, Life Technologies, #A-31571) was used for 4 d at 37 °C. After clearing, samples were imaged on a LaVision Ultramicroscope II with a 2× 0.5-NA objective and on an Olympus FV-1000 twophoton microscope with a 25× 1.05-NA water-immersion objective and a laser tuned at 820 nm. Image stacks were analyzed with Imaris 8.01 (Bitplane).
In situ hybridization. In situ hybridization was performed as described 27 . A Myrf probe corresponding to 941 bp from Myrf 3′ UTR was kindly provided by B. Emery (Oregon Health and Science University, Portland). electron microscopy. Mice were anaesthetized with Avertin (Sigma-Aldrich) and perfused with 15 ml of Hanks balanced salt solution (HBSS, PAA laboratories, Pasching, Austria) followed by fixative (4% PFA, 0.1 M Phosphate buffer, 0.5% NaCl, 2.5% glutaraldehyde). At parasagittal plane, cerebellar lobule V was dissected, contrasted with 1% osmium tetroxide and embedded in epoxy resin. Semithin (0.5 mm) and ultrathin (50-60 nm) sections were cut using a microtome (RM 2155, Leica Microsystems, Wetzlar, Germany) with a diamond knife (Histo HI 4317, Diatome, Biel, Switzerland). Semithin sections were stained with azure-II-methylene blue for 1 min at 60 °C. Ultrathin sections were stained with 2% uranyl acetate (30 min) and 1% lead citrate solution (12 min) and analyzed using a LEO EM912AB electron microscope (Carl Zeiss NTS, Oberkochen, Germany). Images were taken with an on-axis 2,048 × 2,048 CCD camera (Proscan, Scheuring, Germany).
electrophysiology. Parasagittal cerebellar slices (225 µm) were cut using a vibrating blade microtome (Leica VT1200S) from P7-P100 Ng2-EYFP +/− ;Tg(mα6)-Cre;Pten loxP/loxP mice (mutants) and Ng2-EYFP +/− ;Pten loxP/loxP mice (controls), killed by cervical dislocation in accordance with UK government animal use regulations. After dissection, the brain was placed in a cooled (~1 °C) oxygenated (95% O 2 -5% CO 2 ) Krebs solution containing (in mM): 126 NaCl, 24 NaHCO3, 1 NaH 2 PO 4 , 2.5 KCl, 2.5 CaCl 2 , 2 MgCl 2 , 10 d-glucose (pH 7.4). In addition, kynurenic acid was included in order to block glutamate receptors, which might be activated during the dissection procedure and cause cell damage. During experiments, slices were superfused at 22 ± 1 °C with HEPES-buffered external solution containing (in mM): 144 NaCl, 2.5 KCl, 10 HEPES, 1 NaH 2 PO 4 , 2.5 CaCl 2 , 10 glucose, 0.1 glycine (to coactivate NMDA receptors), 0.005 strychnine (to block glycine receptors), pH set to 7.4 with NaOH, bubbled with 100% O 2 . OPCs were identified by EYFP expression and whole-cell voltage clamped. Recording electrodes had a resistance of 5-9 MΩ when filled with an internal solution comprising (in mM): 130 k-gluconate, 4 NaCl, 0.5 CaCl 2 , 10 HEPES, 10 BAPTA, 4 MgATP, 0.5 Na 2 GTP, 2 K-Lucifer yellow, pH set to 7.3 with KOH; the uncompensated series resistance was 40 ± 1 MΩ, and electrode junction potentials (−14 mV) were compensated for. A Multiclamp 700B (Molecular Devices) was used for voltage clamp data acquisition. Data were sampled at 50 kHz and filtered at 10 kHz using pClamp10.3 (Molecular Devices).
Synaptic current analysis.
A synaptic current was defined to occur if its amplitude was greater than twice the s.d. of the baseline current noise and its 10-90% decay time was longer than its rise time. Events were detected and analyzed with pClamp 10.3 (Molecular Devices) and the Strathclyde Electrophysiology Software package WinEDR V3.3.7 WinWCP V4.6.2.
laser-capture microdissection, RNA isolation and linear amplification, and microarray hybridization. Mice were killed at 3 months of age by cervical dislocation; whole brains were dissected and frozen on dry ice, protected with parafilm and stored at −80 °C. Serial coronal cryosections (20 µm) were prepared using a Leica CM3000 Cryostat, mounted on polyethylene naphthalate membrane frame slides (Arcturus), stained with thionin and dried in an ascending ethanol/xylene series. For laser-capture microdissection (LCM), a Veritas Microdissection System (Arcturus) was used, with slides mounted and stained the same day. Cerebellar GL were dissected by ultraviolet laser (laser power set to 3.2-4.2) and attached to CapSure LCM caps using an infrared laser (power set to 80%). Caps were collected in 0.5 ml Eppendorf tubes containing 100 µl of RNeasy Lysis Buffer (Qiagen) and stored at −80 °C. Total RNA was isolated from LCM tissue using the Micro RNeasy Kit (Qiagen) according to the instructions of the manufacturer, except that RNA was eluted from the column with 10 µl of water followed by precipitation with NaAcetate (pH 5.2, f.c. 0.3 M) and PelletPaint (Novagen) as carrier. Two-round amplification and biotin labeling, hybridization to mouse MOE230A 2.0 Genechip arrays (Affymetrix), washing and scanning was conducted essentially as described 28 with three biological replicates for each genotype. Data analysis was performed using Genomics Suite (Partek Inc.). Raw data were normalized using the RMA algorithm, and differentially expressed genes were identified with ANOVA according to the workflow suggested by the manufacturer (Partek Inc.). Differentially expressed genes with signal intensities in mutants > controls were selected with > 1.4-fold change and adjusted P-values < 0.05.
RNA isolation, cdNA synthesis and qRT-PcR. Total RNA was isolated from LCM tissue using the Transcriptor High Fidelity Kit (Roche) according to the instructions of the manufacturer. cDNA was synthesized using a mixture of random nonamer primers, anchored poly-dT primers and SuperScript III RNase H reverse transcriptase (Invitrogen) according to the instructions of the manufacturer. qRT-PCR was performed using SYBR green master mix (Applied Biosystems) and a 7500 Fast Real-Time PCR System (Applied Biosystems). Primers were designed using the Roche Universal ProbeLibrary website (http:// qpcr.probefinder.com). Primer sequences are available upon request. Relative mRNA concentrations were normalized to Actin and Atp5b. Data were analyzed using qBase software version 1.3.5 (Center for Medical Genetics, Ghent University, Ghent, Belgium). mixed myelinating cocultures from mouse spinal cord. Wild-type C57BL/6N mice were time-mated, with the day of plugging denoted as embryonic day 0.5 (E0.5), and embryos were collected on embryonic day 13.5 (E13.5). The spinal cord was dissected and was dissociated mechanically and enzymatically (0.25% trypsin, Invitrogen). Enzymatic activity was stopped by the addition of plating medium (50% DMEM, 25% horse serum, 25% Hank's balanced salt solution without Ca 2+ and Mg 2+ ) containing 2.5 µg/ml DNAse I. Cells were dissociated into a single cell suspension by triturating through 20-and 23-gauge needles (4 and 2 times, respectively) and spun at 800 rpm for 5 min. The pellet was resuspended in plating medium. Dissociated spinal cord cells were initially plated at a density of 150,000 cells/100 µl onto poly-l-lysine (PLL, in boric acid buffer, pH 8.4)-coated coverslips, which were then placed into a 35-mm Petri dish. The cells were left to attach for 2-3 h, after which 150 µl of plating medium and 500 µl of differentiation medium was added. This medium contained DMEM (4,500 mg/L glucose), 10 mg/ml biotin, 0.5% hormone mixture (1 mg/mL apotransferrin, 20 mM putrescine, 4 µM progesterone and 6 µM selenium), 50 nM hydrocortisone and 10 µg/ml insulin (all reagents from Sigma). Cultures were maintained by replacing half of the medium with fresh medium three times per week. After 12 d in culture, cells were fed with differentiation medium with (or without) recombinant human PDGF (100 ng/ml), SPARCL1 (10 ng/ml), VEGFC (100 ng/ml), FGF1 (100 ng/ml), PTN (10 ng/ml), TIMP3 (100 ng/ml), TMSB4X (50 ng/ml) or Activin A (100 ng/ml) and reduced concentration of insulin (0.2 µg/ml). Cultures were maintained for up to 25 days in a humidified atmosphere of 5% CO 2 at 37 °C. mixed primary oligodendrocyte cultures. Mixed primary oligodendrocyte cultures were prepared from (7 pooled) spinal cords of P4 mouse pups. Tissue chunks were incubated in 5 ml papain (200 U) in papain buffer plus l-cysteine for 1 h at ~35 °C with constant gassing (95% oxygen and 5% carbon dioxide). The papain reaction was stopped with plating medium (30% horse serum in DMEM) containing 2.5 µg/ml DNAse I. Cells were dissociated into a single cell suspension by triturating through 20-and 23-gauge needles (4 and 2 times, respectively), spun at 800 rpm for 5 min, and the pellet was resuspended in plating medium. Cells were plated at a concentration of 80,000 cells/100 µl plating medium onto PLL-coated, 11-mm diameter glass coverslips, in 35-mm diameter Petri dishes (2 coverslips/dish). Two hours later, differentiation medium containing DMEM (4,500 mg/L glucose), 10 ng/ml biotin, 0.5% hormone mixture (1 mg/ mL apotransferrin, 20 mM putrescine, 4 µM progesterone and 6 µM selenium), 50 nM hydrocortisone and 10 µg/ml insulin (all reagents from Sigma) was added to each 35-mm Petri dish to yield a mix of 50% plating medium: 50% differentiation medium. The following day all medium and myelin debris was removed from the coverslips by rinsing briefly in medium, and fresh differentiation medium was added to each 35-mm Petri dish, with or without human recombinant forms of KLOTHO (400 ng/ml), PTN (10 ng/ml), TIMP3 (100 ng/ml) or Activin A (100 ng/ml). Cells were fed every second day by replacing half the medium with fresh differentiation medium, including the recombinant proteins. Cultures were maintained for 3 and 5 d in a humidified atmosphere of 5% CO 2 at 37 °C.
Recombinant proteins. Human recombinant proteins were SPARCL1, VEGFC, KLOTHO, TIMP3 and Activin A (R&D Systems), PDGF and PTN (Sigma Aldrich), TMSB4X (Novus Biologicals) and FGFL (Invitrogen). Recombinant proteins were dissolved in ddH 2 O. Individual aliquots were thawed only once and diluted in cell culture medium immediately before use. PI3K inhibitor LY294002 and MEK1/2 inhibitor UO126 were from Cell Signaling Technology; SMAD3 inhibitor SIS3 was from Calbiochem.
Immunocytochemistry. Cells were fixed with 4% PFA for 5 min at 37 °C. After fixation, cultures were washed in PBS three times, permeabilized with ice-cold methanol for 5 min and blocked in blocking buffer (2% fish skin gelatin, 2% FCS, 2% BSA in PBS) for 60 min. Primary antibodies (diluted in 10% blocking buffer) were directed against GFAP ( morphometry. Digitized overlapping light microscopic images (20×) were fused to a continuous image of a complete parasagittal cerebellum (Lateral, 0.12 mm) using Zeiss Zen software and analyzed for absolute numbers of CNP + , CAII + , Olig2 + , Iba1 + , Mac-3 + and BrdU + cells. The number of Iba1 + and Mac-3 + cells were normalized to the areas of ML and GL, respectively. Endothelial cells positive for CD31 were traced with ImageJ and normalized to the area of the ML. To quantify MBP + and GFAP + areas, two ImageJ plugins for semiautomated analysis were implemented (http://www1.em.mpg.de/Goebbels2016_MBP and http://www1.em.mpg.de/Goebbels2016_GFAP). Average diameter of hippocampal CA3 neuronal cell bodies of Nex-CreERT2;Pten loxP/loxP mice was determined by using ImageJ software. Two independent sections per mouse and staining were quantified. In cell culture experiments, the differentiation and proliferation state of oligodendrocyte lineage cells was analyzed within the given fields of 11 randomly taken images (20×) per coverslip (mixed myelinating cultures: myelination assay, 3-11 independent experiments with 2 coverslips per condition; proliferation assay, 3-11 independent experiments with 1 coverslip per condition; mixed primary oligodendrocyte cultures: 3-5 independent experiments with 2 coverslips per condition). For quantitative assessment of in vitro myelination, a 'myelination index' was calculated by dividing the MBP + area (as identified by generating a 'mask' outlining the myelin sheaths; ImageJ plugin: http://www1.em.mpg.de/Goebbels2016_CoCultureMBP) by the axonal area (Smi31 + axons; ImageJ plugin: http://www1.em.mpg.de/Goebbels2016_ CoCultureSmi31). For the proliferation assay, the percentage of semiautomatically quantified Olig2 + cells was determined in relation to all DAPI + cells (Olig2: ImageJ plugin: http://www1.em.mpg.de/Goebbels2016_CoCultureOlig2; DAPI: ImageJ plugin: http://www1.em.mpg.de/Goebbels2016_CoCultureDapi) and the number of Ki67 + Olig2 + cells was set in relation to the total number of Olig2 + cells. For the differentiation assay, the percentage of postmitotic oligodendrocytes was determined by quantifying and dividing the numbers of CC1 + cells by the total number of Olig2 + oligodendrocyte lineage cells. All analyses were performed in a single-blinded fashion toward the investigator, who was unaware of the treatment regimen.
g-ratio measurement. Digitized images (magnification 7,000×) of ultrathin cerebellum lobe 5 sections were used to determine the numbers of myelinated axons, axon calibers and g-ratios (> 100 randomly chosen myelinated axons in the ML). G-ratios were determined by dividing axon diameter by the diameter of the entire fiber (Fig. 1k) or by dividing the inner myelin diameter by the diameter of the entire fiber ( Fig. 3g and Supplementary Fig. 7c ). Quantitations were performed from ≥ 3 age-matched male mice per genotype and age.
Protein analysis. Cerebellum lysates were homogenized in lysis buffer (50 mM HEPES, pH 7.5, 150 mM NaCl, 1.5 mM MgCl2, 5 mM EGTA, 10% glycerol, 1% triton X-100, 2 mM Na 3 VO 4 ) containing phosphatase (PhosSTOP Inhibitor Cocktail, Roche, Basel, Switzerland) and protease (Complete tablets, Roche, Basel, Switzerland) inhibitors using an Ultraturrax (T8, Ika, Staufen, Germany) at its highest settings (30-60 s). After incubation for 15 min on ice, insoluble material was removed by centrifugation at 16,000g at 4 °C for 15 min. For western blot analysis, 10 µg of protein lysate was size-separated on 12% of SDS-polyacrylamide gels and blotted onto PVDF membranes (HybondTM-P, Amersham Biosciences, UK) by Bio-Rad western blotting. Membranes were blocked in 5% milk powder (in PBS) for 1 h at room temperature (20-25 °C) . Primary antibodies were directed against p-AKT1 (Cell Signaling, mRb, 1:1,000, #4060), AKT1 (Cell Signaling, mRb, 1:1,000, #4691), PTEN (Cell Signaling, mRb, 1:1,000, #9188), p-GSK3β (Cell Signaling, mRb, 1:1,000, #9336), p-mTOR (Cell Signaling, mRb, 1:1,000, #5536), p-S6 (Cell Signaling, mRb, 1:1,000, #4858) and Actin (SigmaAldrich, mM, 1:1,000, #A3853). Antibodies were diluted in blocking buffer and incubated overnight at 4 °C. Membranes were washed 3 times for 10 min each time in TBS-T buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl and 0.05% Tween-20), followed by an incubation with horseradish-peroxidase-conjugated secondary antibodies (1:5,000, Dianova, #111-035-003 and #115-035-003). After three more washings with TBS-T buffer, immunoreactive proteins were detected with an enhanced chemiluminescence kit (Western LightningTM, Westernblot Chemiluminescence Reagent Plus, PerkinElmer Life Sciences, Waltham, MA) according to the manufacturer's instructions.
Statistical analysis.
For power analysis we used G*Power Version 3.1.7 software. Power analyses were performed before conducting experiments (a priori). Adequate power (1 -β) was defined as ≥ 80% and the α as 5%. The sample size was calculated with the following prespecified effect sizes:
